Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis
Abstract Background New evidence on the efficacy and safety of dual antiplatelet therapy for secondary stroke prevention have been realized in the recent years. An updated meta analysis was done to determine the effect of the various dual antiplatelets vs aspirin alone on recurrence rate of ischemic...
Main Authors: | Christessa Emille Que Albay, Frederick Gavril D. Leyson, Federick C. Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | BMC Neurology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12883-020-01808-y |
Similar Items
-
Possibilities of antiplatelet therapy in non-cardioembolic ischemic stroke
by: M. Yu. Maksimova, et al.
Published: (2022-06-01) -
Cilostazol-based dual antiplatelet treatment in ischemic stroke or transient ischemic attack patients with asymptomatic carotid artery disease: a propensity score matching analysis
by: Thon Thiraworawong, et al.
Published: (2024-02-01) -
Retraction Note: Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis
by: Christessa Emille Que Albay, et al.
Published: (2020-12-01) -
Dual vs. mono antiplatelet therapy for acute ischemic stroke or transient ischemic attack with evidence of large artery atherosclerosis
by: Chun-Jen Lin, et al.
Published: (2022-09-01) -
Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events
by: Leonardo De Luca, et al.
Published: (2021-04-01)